High-sensitivity C-reactive protein and ankle brachial index in a finnish cardiovascular risk population

International Journal of Angiology

Volumn 20, Issue 1, 2011, Pages 43-47

  Syvanen K ^a   Korhonen, P ^a   Jaatinen, P ^a   Vahlberg, T ^a   Aarnio, P ^a  

^a UNIVERSITY OF TURKU   (Finland)

Author keywords

ankle brachial index; cardiovascular risk factors; High sensitivity C reactive protein

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE;

ADULT; AGE DISTRIBUTION; AGED; ANKLE BRACHIAL INDEX; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; CORRELATIONAL STUDY; FEMALE; GLUCOSE TOLERANCE; HEALTH SURVEY; HIGH RISK POPULATION; HUMAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PATIENT PARTICIPATION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; POPULATION RESEARCH; PREVALENCE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; RISK FACTOR; RURAL POPULATION; SENSITIVITY ANALYSIS; SEX DIFFERENCE; SMOKING; SYSTEMIC CORONARY RISK EVALUATION; WAIST CIRCUMFERENCE;

EID: 80053040848     PISSN: 10611711     EISSN: 16155939     Source Type: Journal    
DOI: 10.1055/s-0031-1272551     Document Type: Article

References (31)

1. Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336:973-979 (Pubitemid 27152782)
2. Ridker PM, Stampfer MJ, Rifai N. Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein(a), and standard cholesterol screening as predictors of peripheral arterial disease. JAMA 2001;285:2481-2485 (Pubitemid 32433842)
3. Danesh J, Wheeler JG, Hirschfield GM, et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 2004; 350:1387-1397 (Pubitemid 38419992)
4. Pearson TA, Mensah GA, Alexander RW, et al; Centers for Disease Control and Prevention; American Heart Association. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003;107:499-511 (Pubitemid 36158056)
5. Reilly MP, Wolfe ML, Localio AR, Rader DJ; Study of Inherited Risk of Coronary Atherosclerosis. C-reactive protein and coronary artery calcification: The Study of Inherited Risk of Coronary Atherosclerosis (SIRCA). Arterioscler Thromb Vasc Biol 2003;23:1851-1856 (Pubitemid 37254874)
6. de Maat MP, Bladbjerg EM, Drivsholm T, Borch-Johnsen K, Moøller L, Jespersen J. Inflammation, thrombosis and atherosclerosis: results of the Glostrup study. J Thromb Haemost 2003;1:950-957
7. Saito M, Ishimitsu T, Minami J, Ono H, Ohrui M, Matsuoka H. Relations of plasma high-sensitivity C-reactive protein to traditional cardiovascular risk factors. Atherosclerosis 2003;167:73-79 (Pubitemid 36255637)
8. Folsom AR, Pankow JS, Tracy RP, et al; Investigators of the NHBLI Family Heart Study. Association of C-reactive protein with markers of prevalent atherosclerotic disease. Am J Cardiol 2001;88:112-117 (Pubitemid 32607694)
9. Elias-Smale SE, Kardys I, Oudkerk M, et al. C-reactive protein is related to extent and progression of coronary and extra-coronary atherosclerosis; results from the Rotterdam study. Atherosclerosis 2007;195:e195-e202 (Pubitemid 350087990)
10. Shankar A, Li J, Nieto FJ, Klein BE, Klein R. Association between C-reactive protein level and peripheral arterial disease among US adults without cardiovascular disease, diabetes, or hypertension. Am Heart J 2007;154:495-501 (Pubitemid 47268244)
11. Vu JD, Vu JB, Pio JR, et al. Impact of C-reactive protein on the likelihood of peripheral arterial disease in United States adults with the metabolic syndrome, diabetes mellitus, and preexisting cardiovascular disease. Am J Cardiol 2005;96: 655-658 (Pubitemid 41207307)
12. Lindström J, Tuomilehto J. The diabetes risk score: a practical tool to predict type 2 diabetes risk. Diabetes Care 2003;26:725-731 (Pubitemid 36929335)
13. Conroy RM, PyöräläK, Fitzgerald AP, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24:987-1003 (Pubitemid 36712275)
14. Parati G, Stergiou GS, Asmar R, et al; ESH Working Group on Blood Pressure Monitoring. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens 2008;26:1505-1526
15. World Health Organization (WHO). Definition and Diagnosis of Diabetes Mellitus and Intermediate Hyperglycemia. Report of a WHO/IDF Consultation. Geneva, Switzerland: World Health Organization; 2006
16. Alberti KG, Zimmet P, Shaw J; IDF Epidemiology Task Force Consensus Group. The metabolic syndrome-a new worldwide definition. Lancet 2005;366:1059-1062
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497
18. Korhonen P, Aarnio P, Saaresranta T, Jaatinen P, Kantola I. Glucose homeostasis in hypertensive subjects. Hypertension 2008;51:945-949 (Pubitemid 351654709)
19. Pande RL, Perlstein TS, Beckman JA, Creager MA. Association of insulin resistance and inflammation with peripheral arterial disease: the National Health and Nutrition Examination Survey, 1999 to 2004. Circulation 2008;118: 33-41
20. Eldrup N, Sillesen H, Prescott E, Nordestgaard BG. Ankle brachial index, C-reactive protein, and central augmentation index to identify individuals with severe atherosclerosis. Eur Heart J 2006;27:316-322 (Pubitemid 43100027)
21. Bo M, Corsinovi L, Brescianini A, et al. High-sensitivity Creactive protein is not independently associated with peripheral subclinical atherosclerosis. Angiology 2009;60:12-20
22. Hak AE, Stehouwer CDA, Bots ML, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol 1999;19:1986-1991 (Pubitemid 29379933)
23. Ford ES. Body mass index, diabetes, and C-reactive protein among U.S. adults. Diabetes Care 1999;22:1971-1977 (Pubitemid 30433974)
24. Planas A, Clará A, Pou JM, et al. Relationship of obesity distribution and peripheral arterial occlusive disease in elderly men. Int J Obes Relat Metab Disord 2001;25:1068-1070 (Pubitemid 32566064)
25. Despres JP. Abdominal obesity: the most prevalent cause of the metabolic syndrome and related cardiometabolic risk. Eur Heart J Suppl 2006;8(Suppl B):4-12
26. Carbayo JA, Divisón JA, Escribano J, et al; Grupo de Enfermedades Vasculares de Albacete (GEVA). Using anklebrachial index to detect peripheral arterial disease: prevalence and associated risk factors in a random population sample. Nutr Metab Cardiovasc Dis 2007;17:41-49 (Pubitemid 44911087)
27. Yanbaeva DG, Dentener MA, Creutzberg EC, Wesseling G, Wouters EF. Systemic effects of smoking. Chest 2007;131: 1557-1566 (Pubitemid 46762366)
28. Thorand B, Baumert J, Döring A, et al; KORA Group. Sex differences in the relation of body composition to markers of inflammation. Atherosclerosis 2006;184:216-224 (Pubitemid 41721091)
29. Ahonen TM, Kautiainen HJ, Keinänen-Kiukaanniemi SM, Kumpusalo EA, Vanhala MJ. Gender difference among smoking, adiponectin, and high-sensitivity C-reactive protein. Am J Prev Med 2008;35:598-601
30. Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). Eur J Vasc Endovasc Surg 2007;33(Suppl 1):1-75
31. Espinola-Klein C, Rupprecht HJ, Bickel C, et al; Athero-Gene Investigators. Different calculations of ankle-brachial index and their impact on cardiovascular risk prediction. Circulation 2008;118:961-967